U.S. Paper and Forestry Products Stock News

Willis Towers Watson (NasdaqGS:WTW) has completed its acquisition of Newfront Insurance Holdings. The deal brings Newfront's technology-enabled insurance platform and specialty expertise into WTW's U.S. operations. The transaction expands WTW's reach in the U.S. middle market and strengthens its data-driven insurance and risk solutions. For investors watching NasdaqGS:WTW, the Newfront acquisition comes as the shares trade around $316.25, with a 5 year return of 61.4% and a 3 year return of...

Tetra Tech (TTEK) opened fiscal Q1 2026 with revenue of US$1.0b and basic EPS of US$0.40, setting the tone for a quarter where headline figures and profit quality are front of mind for investors. The company has seen quarterly revenue move from US$1.20b in Q1 2025 to US$1.04b in Q1 2026, while basic EPS shifted from roughly flat at US$0.00 in Q1 2025 to US$0.40 in the latest quarter, alongside trailing twelve month EPS of US$1.34 on revenue of US$4.5b. With net income tracking higher on a...

Earlier this week, Hubbell Incorporated launched its Aclara360 software and showcased new grid automation solutions, highlighting enhanced grid-edge analytics, remote diagnostics, and integration with utilities’ existing systems. A key insight is Aclara360’s focus on extracting more value from utilities’ current infrastructure, aiming to improve reliability and operational efficiency without major capital outlays. We’ll now examine how Aclara360’s grid-edge analytics capabilities shape...

Align Technology is seeing shrinking returns on capital and free cash flow margins, pointing to pressure on its clear aligner business. These trends suggest the company may need additional investment to support competitiveness in a crowded orthodontics market. The changes in profitability and cash generation come as investors reassess NasdaqGS:ALGN after a 27.2% decline over the past year. For you as an investor, the key context is that Align Technology, trading at $164.12, has seen its...

Carter Bankshares (CARE) has wrapped up FY 2025 with fourth quarter revenue of US$42.1 million and basic EPS of US$0.39, supported by trailing twelve month revenue of US$157.1 million and EPS of about US$1.40. The company has seen revenue move from US$140.9 million and basic EPS of about US$1.06 on a trailing basis at the end of 2024 to the latest trailing figures. This gives investors a clearer sense of how earnings power has evolved through the year and what that might mean for margins...

Louisiana-Pacific stock reaction and recent performance snapshot Louisiana-Pacific (LPX) has been trading around $86.44, with returns mixed across time frames, including a 2.3% decline over the past day and a 6.7% decline over the past week. Over the past month, the stock shows a 5.0% gain, while the past 3 months reflect a 0.8% decline and the 1 year total return sits at a 25.9% decline, giving investors a varied recent performance picture. See our latest analysis for Louisiana-Pacific. The...

What Archer Aviation’s recent performance means for investors Archer Aviation (ACHR) has been on many watchlists after a mixed stretch in the share price, with a 3.9% decline in the last day and negative returns over the past month and past 3 months. See our latest analysis for Archer Aviation. At the current share price of US$7.43, Archer Aviation’s short term momentum has softened, with a 7 day share price return of 17.54% and a 90 day share price return of 33.78%, while the 3 year total...

Recent news around Tutor Perini’s contract wins and stabilizing margins has reinforced the strength of its civil and building backlog, while analysts now anticipate significantly higher earnings and revenue in the upcoming results compared with prior periods. What stands out is how incremental contract updates and favorable analyst expectations are reshaping perceptions of the durability and quality of Tutor Perini’s project pipeline. We’ll now look at how optimism around upcoming earnings...

Celcuity (CELC) has moved into focus after the FDA accepted its New Drug Application for gedatolisib in HR+/HER2-, PIK3CA wild-type advanced breast cancer, granting Priority Review and setting a July 17, 2026 PDUFA date. See our latest analysis for Celcuity. That regulatory milestone comes after a strong run in the stock, with a 30 day share price return of 12.21%, a 90 day share price return of 45.31%, and a very large 1 year total shareholder return. This suggests momentum has been building...

Why H.B. Fuller Is On Investors’ Radar Today H.B. Fuller (FUL) has attracted attention after recent share price moves, with the stock last closing at $60.38. For investors, the key question is how this price connects to the company’s fundamentals. See our latest analysis for H.B. Fuller. The recent 1-day share price return of 1.26% comes after a mixed period, with a 90-day share price return of 5.25% contrasting with a 1-year total shareholder return decline of 3.39%. This suggests momentum...

In the fourth quarter of 2025, Banc of California, Inc. reported net interest income of US$251.36 million and net income of US$77.39 million, with management highlighting strong execution in loan and deposit growth. An interesting angle for investors is management’s emphasis on attracting new high-quality client relationships and late-quarter loan growth as key supports for the bank’s core earnings power. We’ll now examine how the bank’s focus on high-quality relationship growth and...

Murphy Oil (MUR) closed out FY 2025 with Q4 revenue of US$613.1 million and basic EPS of US$0.08, supported by net income excluding extra items of US$11.6 million. Over the last few quarters, the company has seen revenue move between US$663.3 million and US$720.97 million, while quarterly EPS has ranged from a loss of US$0.02 to a profit of US$0.51. The trailing 12 months add up to revenue of US$2.7 billion and EPS of US$0.72. With a trailing net profit margin of 3.9% compared with a prior...

Federal Signal stock overview Federal Signal (FSS) is drawing investor attention after recent trading left the shares with a total return over the past 3 months of around an 8% decline, compared with a 1 year total return of about 10%. See our latest analysis for Federal Signal. Recent trading has been softer, with a 7 day share price return of a 5.64% decline and a 90 day share price return of an 8.26% decline. This comes even as the 1 year total shareholder return of about 10% and 5 year...

In January 2026, Amalgamated Financial Corp. reported higher fourth‑quarter 2025 results, with net interest income of US$77.85 million and net income of US$26.64 million, alongside increased earnings per share from continuing operations versus a year earlier. At the same time, the company signaled a stronger focus on shareholder returns by raising its quarterly dividend to US$0.17 per share and completing a share repurchase tranche totaling 1.04 million shares for US$31.03 million. With this...

Meritage Homes (MTH) just closed out FY 2025 with fourth quarter revenue of US$1.4b and basic EPS of US$1.21, while trailing twelve month revenue came in at US$5.9b with basic EPS of US$6.40. Over recent quarters the company has seen revenue move from US$1.6b and EPS of US$2.39 in Q4 2024 to US$1.6b and EPS of US$2.06 in Q2 2025, before landing at the latest Q4 2025 levels. With net profit margins easing from 12.3% to 7.7% over the last year, this set of results gives investors plenty to...

Altria Group (MO) has rounded out FY 2025 with fourth quarter revenue of US$5.8b and basic EPS of US$0.67, setting the stage for a full year where trailing twelve month revenue sits at US$23.3b and EPS at US$4.13. Over the last few quarters, the company has seen quarterly revenue range from US$4.5b to US$5.8b while basic EPS has moved between roughly US$0.64 and US$1.41, giving investors a clear read on how the earnings line tracks against the top line. With a trailing net margin of 29.8%...

Satellogic (SATL) is back in focus after extending its national satellite monitoring agreement with the Albanian government for another 11 months, reinforcing recurring demand for its Earth observation services from a sovereign client. See our latest analysis for Satellogic. The contract extension arrives just days after Satellogic completed a series of follow on equity offerings totaling about US$46.5m. The stock has been volatile, with a 1 day share price return of a 2.42% decline, a 30 day...

Global Partners (GLP) has attracted fresh attention after recent trading left the units at $47.84, with returns of 2.3% over the past day, 7.5% over the past week, and 12.1% over the past month. See our latest analysis for Global Partners. Those short term share price gains come after a steadier period, with a 90 day share price return of 5.8% and year to date share price return of 13.2%. The 1 year total shareholder return of 10.3% contrasts with a much stronger 5 year total shareholder...

Event context and recent stock performance Northwest Natural Holding (NWN) has drawn fresh attention after recent price moves, with the stock last closing at $47.05. Short term returns are around 1% over the past week and month, and about 3% over the past 3 months. See our latest analysis for Northwest Natural Holding. Zooming out, the share price has been fairly steady this year, while the 1 year total shareholder return of 22.99% and 5 year total shareholder return of 29.90% point to a...

Korn Ferry (NYSE:KFY) has been appointed Founding Partner for the LA28 Olympic and Paralympic Games. The firm will serve as the Official Talent & Organizational Consulting Partner for LA28. Korn Ferry will support hiring, onboarding, and development of the workforce preparing for the 2028 Games in Los Angeles. Korn Ferry, a global organizational consulting firm, is moving into a very visible role with the LA28 Olympic and Paralympic Games. The company is known for work across executive...

American Riviera Bancorp (ARBV) has rounded out FY 2025 with fourth quarter revenue of about US$14.4 million and EPS of US$0.80, capping a trailing twelve month run that produced revenue of roughly US$50.4 million and EPS of US$2.18. Over the past year, revenue has moved from US$44.5 million to US$50.4 million and EPS from US$1.50 to US$2.18, alongside earnings growth of 42.4% and a net profit margin of 24.7% versus 19.6% a year earlier. This gives investors a clearer view of how the business...

Thermo Fisher Scientific (TMO) closed out FY 2025 with fourth quarter revenue of US$12.2b and basic EPS of US$5.25, alongside net income of US$1.96b, setting a clear benchmark for how the year wrapped up. Over the past six quarters, the company has seen quarterly revenue range from US$10.4b to US$12.2b and basic EPS move between US$3.99 and US$5.25. This gives investors a detailed view of how the top and bottom line have tracked through FY 2024 and FY 2025. With trailing 12 month EPS at...

Coda Octopus Group (CODA) closed out FY 2025 with Q4 revenue of US$7.3 million and basic EPS of US$0.09, alongside net income of US$1.0 million that builds on a trailing 12 month net income base of US$4.1 million. The company has seen quarterly revenue move from US$5.1 million in Q1 2025 to US$7.3 million in Q4, while basic EPS ranged between US$0.08 and US$0.11 over the year. This sets up a picture where investors are weighing higher recent profit levels against net margins that have...

Teva Pharmaceutical Industries (NYSE:TEVA) partnered with actor Will Forte to raise awareness of Huntington's disease and support patient education efforts. The company reported progress in its branded drug transformation, with advances in its pipeline and execution of key growth milestones. These updates highlight Teva's dual focus on central nervous system conditions such as Huntington's disease and on reshaping its branded medicines portfolio. For you as an investor, Teva sits at the...